(19)
(11) EP 1 379 229 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
30.05.2007 Bulletin 2007/22

(45) Mention of the grant of the patent:
28.02.2007 Bulletin 2007/09

(21) Application number: 02720429.6

(22) Date of filing: 26.03.2002
(51) International Patent Classification (IPC): 
A61K 31/19(2006.01)
 A61P 35/00(2006.01)
(86) International application number:
PCT/IL2002/000259
(87) International publication number:
WO 2002/080890 (17.10.2002 Gazette 2002/42)

(54)

A JASMONATE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER

ARZNEIMITTEL ENTHALTEND JASMONAT ZUR BEHANDLUNG VON KREBS

COMPOSITION PHARMACEUTIQUE DE JASMONATE POUR LE TRAITEMENT DU CANCER

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 04.04.2001 US 825347

(43) Date of publication of application:
14.01.2004 Bulletin 2004/03

(73) Proprietor: Ramot at Tel Aviv University Ltd.
69975 Tel Aviv (IL)

(72) Inventors:
  • FLESCHER, Eliezer
    45272 Hod Hasharon (IL)
  • FINGRUT, Orit
    44233 Kfar-Sava (IL)

(74) Representative: Vossius & Partner 
Siebertstrasse 4
81675 München
81675 München (DE)


(56) References cited: : 
   
  • DATABASE WPI Section Ch, Week 199815 Derwent Publications Ltd., London, GB; Class B05, AN 1998-163664 XP002203872 & JP 10 029935 A (NOEVIR KK), 3 February 1998 (1998-02-03)
  • DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; TORII, KOUSUKE ET AL: "Evaluation of anti- androgen effect using SC-3 cells" retrieved from STN Database accession no. 127:200188 XP002203871 & NIPPON KOSHOHIN KAGAKKAISHI (1997), 21(2), 97-102 ,
  • DERMASTIA, MARINA ET AL: "The effects of a plant growth regulator, jasmonic acid, on some mammalian fibroblast cell lines" ACTA PHARM. (ZAGREB) (1992), 42(4), 347-50 , XP001085225
  • DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; April 2002 (2002-04) FINGRUT O ET AL: "Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells." Database accession no. PREV200200324956 XP000185234 & LEUKEMIA (BASINGSTOKE), vol. 16, no. 4, April 2002 (2002-04), pages 608-616, ISSN: 0887-6924
  • SCHIERLE K ET AL: "Homologues of Dihydro-12-oxo-phytodienoic Acid and Jasmonic Acid by Mixed Kolbe Electrolysis" TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 37, no. 48, 25 November 1996 (1996-11-25), pages 8715-8718, XP004068758 ISSN: 0040-4039
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).